AbbVie Stock (NYSE: ABBV) stock price, news, charts, stock research, profile.
Open | $168.520 |
Close | $167.800 |
Volume / Avg. | 4.075M / 5.623M |
Day Range | 166.740 - 169.110 |
52 Wk Range | 130.960 - 182.890 |
Market Cap | $297.115B |
P/E Ratio | 62.331 |
Dividend Yield | 3.660% |
Exchange | NYSE |
RSI | 44 |
Short Interest | 0.74% |
Days to Cover | 2.25 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of AbbVie (NYSE: ABBV) through any online brokerage.
Other companies in AbbVie’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
The latest price target for AbbVie (NYSE: ABBV) was reported by Barclays on Wednesday, March 27, 2024. The analyst firm set a price target for 195.00 expecting ABBV to rise to within 12 months (a possible 16.21% upside). 24 analyst firms have reported ratings in the last year.
The stock price for AbbVie (NYSE: ABBV) is $167.8 last updated Today at April 24, 2024 at 5:34 PM EDT.
A quarterly cash dividend of $1.55 per share of Class A Common Stock. The quarterly cash dividend was payable on May 15, 2024 to stockholders of record on April 12, 2024.
AbbVie’s Q1 earnings are confirmed for Friday, April 26, 2024.
There is no upcoming split for AbbVie.
AbbVie is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.